Clinical Research Directory
Browse clinical research sites, groups, and studies.
Treatment of Overactive Bladder With Anticholinergic Agents
Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Summary
This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.
Official title: Evaluation of Anticholinergic Treatment Response and Predictive Factors in Pediatric Overactive Bladder
Key Details
Gender
All
Age Range
5 Years - 17 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2022-09-01
Completion Date
2026-06-01
Last Updated
2025-07-01
Healthy Volunteers
No
Conditions
Interventions
Oxybutynin Cl
Oxybutynin in a dose of 0.5 mg/kg will be used in the treatment of overactive bladder
propiverine
Propiverine in a dose of 0.8 mg/kg will be used in the treatment of overactive bladder
Tolterodine
Tolterodine in a dose of 0.1 mg/kg will be used in the treatment of overactive bladder
Locations (1)
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital
Istanbul, Turkey (Türkiye)